Skip to main content
. 2023 Jun 26. Online ahead of print. doi: 10.1016/S2666-5247(23)00115-5

Table 3.

Presence of SARS-CoV-2 in neonates and fetuses

Country Sample size Age (years) Sex Diagnosis of COVID-19 complication Baseline severity of COVID-19 Biopsy or autopsy Organs analysed Findings Time between the acute infection and biopsy or autopsy Evidence of virus or viral fragments or antibodies
Schwartz et al (2022)37 International 6 Fetuses No reported Maternal COVID in pregnancy Critical COVID-19 Autopsy Whole body 4 of 6 autopsied stillborns babies had SARS-CoV-2 in internal organs (lung, brain, kidney, and heart) Not reported Viral RNA
Lesieur et al (2021)38 France 1 Fetus Female Maternal COVID-19 in pregnancy Mild Autopsy Thymus, lung, bronchial tree, stomach, spleen, adrenal gland, kidney, oesophagus, liver, heart, pancreas, and trachea RNA and spike protein found in lungs, and liver; RNA found in spleen and thymus; spike protein found in the stomach, heart, and lymph nodes 11 days Viral RNA and spike protein
Reagan-Steiner et al (2022)39 2022 1 1 day Male Critical COVID-19 Critical COVID-19 Autopsy Whole body SARS-CoV-2 RNA detected in lung, airway, heart, liver, spleen, and kidney tissue by conventional RT-PCR; subgenomic RNA, suggesting SARS-CoV-2 replication, detected by subgenomic RT-PCR in lung, airway, heart, and liver tissue, but not in spleen or kidney tissue 6 days from maternal infection Viral RNA